MTF Biologics Appoints Jeff Orlowski to Board of Directors
EDISON, N.J.–(BUSINESS WIRE)–MTF Biologics, a global nonprofit organization that saves and heals lives by honoring…
News
Latest Clinical Evidence Points to Paragonix SherpaPak® as a Tool to Reduce Unpredictable, Severe Complications following Heart Transplantation
GUARDIAN Registry data presented at ACC 2023 has shown use of the Paragonix SherpaPak® Cardiac…
Mountain Valley MD Announces Stock Option Grant
TORONTO, March 06, 2023 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
Trailbreaker Closes of Financing
VANCOUVER, British Columbia, March 06, 2023 (GLOBE NEWSWIRE) — Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or…
Facility Vitals Software Inc. Launches Revolutionary Facility Management Software Solution
Vancouver, British Columbia–(Newsfile Corp. – March 6, 2023) – Facility Vitals, a prominent provider of…
System Pavers Recognized as a 2023 Orange County Top Workplace
Leading Outdoor Living Remodeling Company Awarded by Orange County Register for Four Consecutive Years SANTA…
vTv Therapeutics Announces 2022 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Company preparing to initiate Phase 3 clinical trials of TTP399, an adjunctive therapy to insulin,…
MDxHealth Announces Exercise of Option
NEWS RELEASE – REGULATED INFORMATION MARCH 6, 2023, 5:30 pm ET/ 23:30 CET IRVINE, CA,…
Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update
NEW YORK, March 06, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (Euronext Growth: ALCLS – NASDAQ:…
Day One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Progress
First patient dosed in pivotal Phase 3 FIREFLY-2/LOGGIC trial evaluating tovorafenib (DAY101) as a frontline…
ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 06, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Eloxx Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
WATERTOWN, Mass., March 06, 2023 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader…
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
Progressing IND-enabling studies for ETX-123 and further preclinical development of Kv7.2/3 channel opener program Implemented corporate…
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023
TUSTIN, Calif., March 06, 2023 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics…
Amarin Announces Board Departures
DUBLIN, Ireland and BRIDGEWATER. N.J., March 06, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:…
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
PALO ALTO, Calif., March 06, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”),…
Cyclacel Pharmaceuticals Reports Fourth Quarter And Full Year 2022 Financial Results And Provides Business Update
– On Track to Start Oral Fadraciclib Phase 2 Proof of Concept in 1H 2023…
Immuneering Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
First patient dosed in Phase 1/2a clinical trial of IMM-1-104 in advanced solid tumors with…
Akoya Reports Record Revenue in the Fourth Quarter of 2022 and Provides Full Year 2023 Revenue Guidance
Q4 2022 revenue $21.2 million and FY 2022 revenue $74.9 millionFY 2023 revenue guidance range…
Evertz Technologies Limited Delivers Expression of Interest to Acquire Haivision Systems Inc.
Burlington, Ontario–(Newsfile Corp. – March 6, 2023) – Evertz Technologies Limited (TSX: ET) (“Evertz”) announces…